Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates

Synapse

Volumn 25, Issue 1, 1997, Pages 1-14

  Laruelle, Marc ^a,b,d   Iyer, Raj N ^a,b   Al Tikriti, Mohammed S ^a,b   Zea Ponce, Yolanda ^a,b   Malison, Robert ^a,b   Zoghbi, Sami S ^a,b   Baldwin, Ronald M ^a,b   Kung, Hank F ^c   Charney, Dennis S ^a,b   Hoffer, Paul B ^a,b   Innis, Robert B ^a,b   Bradberry, Charles W ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

alpha methyl para tyrosine; amphetamine; dopamine; dopamine D2 receptors; microdialysis; SPECT

Indexed keywords

AMPHETAMINE; BENZAMIDE DERIVATIVE; DIHYDROBENZOFURAN DERIVATIVE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; IODINE 123; METIROSINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; ISOTOPE LABELING; MICRODIALYSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIMATE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMPHETAMINE; ANIMALS; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA; MALE; MICRODIALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031030271     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H     Document Type: Article

References (63)

1. Abi-Dargham, A., Gandelman, M., Zoghbi, S.S., Laruelle, M., Baldwin, R.M., Randall, P., Zeaponce, Y., Charney, D.S., Hoffer, P.B., and Innis, R.B. (1995) Reproducibility of SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil. J. Nucl. Med., 36:167-175.
2. 2 receptors. Nucl. Med. Biol., 21:179-188.
3. 2 dopamine receptors in human Y-79 retinoblastoma cells. Mol. Pharmacol., 39:650-658.
4. Bradberry, C.W., and Roth, R.H. (1989) Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci. Lett., 103:97-102.
5. Bradberry, C.W., Sprouse, J.S., Aghajanian, G.K., and Roth, R.H. (1991) Sub-picogram determination of serotonin using HPLC with electrochemical detection for microdialysis studies of serotonin release. In: Kynurenine and Serotonin Pathways. R. Schwarzc, S.N. Youn, and R.R. Brown eds., Plenum Press, New York, pp. 81-89.
6. Butcher, S.P., Fairbrother, I.S., Kelly, J.S., and Arbuthnott, G.W. (1988) Amphetamine-induced dopamine release in rat striatum: An in vivo microdialysis study. J. Neurochem., 50:346-355.
7. 18F]cyclofoxy and positron emission tomography. J. Cereb. Blood Flow Metab., 13:24-42.
8. 50) of an enzymatic reaction. Biochem. Pharmacol., 22:3099-3108.
9. DeJesus, O.T., Van Moffaert, G.J.C., Dinerstein, R.J., and Friedman, A.M. (1986) Exogenous L-DOPA alters spiroperidol binding, in vivo, in the mouse striatum. Life Sci., 39:341-349.
10. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse, 13:350-356.
11. Engelman, K., Horwitz, D., Jequier, E., and Sjoerdsma, A. (1968) Biochemical and pharmacologic effects of alpha-methyltyrosine in man. J. Clin. Invest., 47:577-594.
12. 11C]raclopride. Arch. Gen. Psychiatry, 47:213-219.
13. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch. Gen. Psychiatry, 49:538-544.
14. Florin, S., Kuczenski, R., and Segal, D.S. (1995) Effect of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: Mechanistic and behavioral consideration. J. Pharmacol. Exp. Ther., 274:231-241.
15. Frost, J.J., and Wagner, H.N., Jr. (1984) Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters. Brain Res., 305:1-11.
16. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24.
17. 2 receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch. Gen. Psychiatry, 51:116-123.
18. 2 receptor in non-human primates. Synapse, 10:177-184.
19. Iyer, R.N., Nobiletti, J.B., Jatlow, P.I., and Bradberry, C.W. (1995) Cocaine and cocaethylene: Effects on extracellular dopamine in the primate. Psychopharmacology, 120:150-155.
20. Johnson, R.D., and Justice, C.B. (1983) Model studies for brain dialysis. Brain Res. Bull., 10:567-571.
21. D with the opiate antagonist cyclofoxy: Equilibrium studies in the conscious rat. J. Cereb. Blood Flow Metab., 11:529-544.
22. 2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J. Nucl. Med., 32:1593-1600.
23. 2 radioligands in rhesus monkeys. J. Nucl. Med., 34:132P.
24. 2 receptors. Synapse, 15:169-176.
25. Kinable, M.B., Jones, D.W., Coppola, R., Hyde, T.M., Lee, K.S., Gorey, J., and Weinberger, D.R. (1995) Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease. J. Nucl. Med., 36:1216-1225.
26. Kirk, R.E. (1982) Experimental Design: Procedures for the Behavioral Sciences. Brooks/Cole Publishing Company, Pacific Grove, CA.
27. 3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors. Eur. J. Pharmacol., 72:397-402.
28. Kuczenski, R., and Segal, D. (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci., 9:2051-2065.
29. 125I]IBZM: A potential CNS D-2 dopamine receptor imaging agent. Nucl. Med. Biol., 15:195-201.
30. Kung, H.F., Kasliwal, R., Pan, S., Kung, M.-P., Mach, R.H., and Guo, Y.-Z. (1988b) Dopamine D-2 receptor imaging radiopharmaceuticals: Synthesis, radiolabeling, and in vitro binding of R-(+)-and S-(-)-3-iodo-2-hydroxy-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J. Med. Chem., 31:1039-1043.
31. 123I]IBZM, a potential dopamine D-2 receptor imaging agent. J. Lab. Comp. Radiopharm., 27:691-700.
32. Kung, M.-P., Kung, H.F., Billings, J., Yang, Y., Murphy, R.A., and Alavi, A. (1990) The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J. Nucl. Med., 31:648-654.
33. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J. Cereb. Blood Flow Metab., 14:453-465.
34. 123I]iodobenzofuran and single photon emission computerized tomography. Eur. J. Pharmacol., 263:39-51.
35. 123I]iomazenil binding to benzodiazepine receptors in nonhuman primates. I. Kinetic modeling of single bolus experiments. J. Cereb. Blood Flow Metab., 14:439-452.
36. 2 receptors in healthy subjects. J. Nucl. Med., 35:743-754.
37. Laruelle, M., Abi-Dargham, A., van Dyck, C.H., Rosenblatt, W., Zea-Ponce, Y., Zoghbi, S.S., Baldwin, R.M., Charney, D.S., Hoffer, P.B., Kung, H.F., and Innis, R.B. (1995) SPECT imaging of striatal dopamine release after amphetamine challenge. J. Nucl. Med., 36:1182-1190.
38. 2 dopamine receptor of patients with Parkinson's disease using single photon emission computed tomography and iodobenzamide I 123. Ann. Neurol., 50:509-512.
39. 18F]N-methylspiperidol binding in the basal ganglia: Comparison of simulations and experimental results from PET studies in baboons. Synapse, 9:195-207.
40. 123I]β-CIT SPECT measures of dopamine transporter availability in human cocaine addicts. Psychopharmacology, 122:358-362.
41. Mintun, M.A., Raichle, M.E., Kilbourn, M.R., Wooten, G.F., and Welch, M.J. (1984) A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol., 15:217-227.
42. Murphy, R.A., Kung, H.F., Kung, M.-P., and Billings, J. (1990) Synthesis and characterization of iodobenzamide analogs: Potential D-2 dopamine receptor imaging agents. J. Med. Chem., 33:171-178.
43. Nash, J.F., and Yamamoto, B.K. (1993) Effect of D-amphetamine on the extracellular concentrations of glutamate and dopamine in iprindole-treated rats. Brain Res., 627:1-8.
44. Paulson, P.E., and Robinson, T.E. (1995) Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats. Synapse, 19:56-65.
45. Pearl, R.G., and Seiden, L.S. (1979) d-amphetamine-induced increase in cathecolamine synthesis in the corpus striatum of the rat: Persistence of the effect after tolerance. J. Neural Transm., 44:21-38.
46. Perry, D.C., Mullis, K.B., Øie, S., and Sadee, W. (1980) Opiate antagonist receptor binding in vivo: Evidence for a new receptor binding model. Brain Res., 199:49-61.
47. Robinson, T.E., and Becker, J.B. (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev., 11:157-198.
48. Ross, S.B. (1991) Synaptic concentration of dopamine in the mouse striatum in relationship to the kinetic properties of the dopamine receptors and uptake mechanism. J. Neurochem., 56:22-29.
49. Ross, S.B., and Jackson, D.M. (1989a) Kinetic properties of the in vivo accumulation of the dopamine D-2 receptor antagonist raclopride in the mouse brain in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 340:6-12.
50. 3H](-)-N-n-propylnorapomorphine in the mouse brain. Naunyn Schmiedebergs Arch. Pharmacol., 340:13-20.
51. Saunders, R.C., Aigner, T.G., and Frank, J.A. (1990) Magnetic resonance imaging of the rhesus monkey brain: Use for stereotactic neurosurgery. Exp. Brain Res., 81:443-446.
52. Schwarz, R.D., Uretsky, N.J., and Bianchine, J.R. (1980) The relationship between the stimulation of dopamine synthesis and release produced by amphetamine and high potassium striatal slices. J. Neurochem., 35:1120-1127.
53. Seeman, P., and Grigoriadis, D. (1987) Dopamine receptors in brain and periphery. Neurochem. Int., 10:1-25.
54. 3H]raclopride: Implications for positron emission tomography of the human brain. Synapse, 3:96-97.
55. 2 receptors in human subjects with iodine-123-IBZM. J. Nucl. Med., 33:1964-1971.
56. Sharp, T., Zetterstrom, T., Ljungberg, T., and Ungerstedt, U. (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine rlease in the rat using intracerebral dialysis. Brain Res., 401:322-330.
57. 2 dopamine receptor. J. Biol. Chem., 257:6351-6361.
58. Spector, S., Sjoerdsma, A., and Udenfriend, S. (1965) Blockade of endogenous norepinephrine synthesis by alpha-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther., 147:86-95.
59. Van der Werf, J.F., Sebens, J.B., Vaalburg, W., and Korf, J. (1986) In vivo binding of N-n-propylnorapomorphine in the rat brain: Regional localization, quantification in striatum and lack of correlation with dopamine metabolism. Eur. J. Pharmacol., 87:259-270.
60. Volkow, N.D., Fowler, J.S., Wang, G.J., Dewey, S.L., Schyler, D., MacGregor, R., Logan, J., Alexoff, D., Shea, C., Hitzemann, R., Angrist, B., and Wolf, A.P. (1993) Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J. Nucl. Med., 34:609-613.
61. 11C]raclopride in the human brain. Synapse, 16:255-262.
62. Wang, J., Skirboll, S., Aigner, T.G., Saunders, R.C., Hsiao, J., and Bankiewicz, K.S. (1990) Methodology of microdialysis of neostriatum in hemiparkinsonian nonhuman primates. Exp. Neurol., 110:181-186.
63. 3H]raclopride binding in the rat brain. Synapse, 9:188-194.